Clinical Trial: ELITE: Deep Profiling and Algorithmic Polytherapy to Map Individual Response in Healthy Aging

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07871799) titled 'ELITE: Deep Profiling and Algorithmic Polytherapy to Map Individual Response in Healthy Aging' on Oct. 03.

Brief Summary: ELITE, Evidence-Based Longevity Interventions and Targeted Engagement, was a randomized, open-label, two-active-arm Phase IIa pilot conducted at Sheba Medical Center in Ramat Gan, Israel. The purpose of ELITE was to characterize individual response to multidomain healthy-aging interventions over approximately eight weeks by combining a clinical measure of muscular, immune and cognitive function with frequent digital monitoring between study visits. The primary outcome was change from baseline to Week 8 in the Mus...